Abstract
New data from HSBC Innovation Banking add further evidence venture capital funding for private biotechnology companies has slid lower as the year has progressed, erasing what was a fast start to 2025.
Key Data
-
Publication Date17 July 2025
-
Primary AuthorGwendolyn Wu
-
SourceBioPharma Dive
-
LanguageEnglish
Click below to visit original source: